Study Links GLP-1 Agonists to Reduced Cardiovascular Risk | Retatrutide News

GLP-1 agonists have been associated with lower risks of heart attack and stroke, according to a major study. This finding is relevant for the developmen...
Clinical Trials · November 5, 2026